Stay updated with breaking news from Augustine Ventures Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/CNW/ - Seven Oaks Capital Corp. (TSXV: SEVN.P) (the Company" or "Seven Oaks") is pleased to announce that it has entered into a binding letter agreement dated...
Accredited Investor email list Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above. By completing this form, you are giving consent to receive communication from Silo Wellness using the contact information you provide. And remember you can unsubscribe at any time. Silo Wellness’ Management Team & Board of Directors Douglas Gordon — CEO (J...
Halo Collective Taps Have a Heart's CEO Ryan Kunkel Halo Collective Inc. (NEO:HALO)(OTCQX:AGEEF) has welcomed Have a Heart's CEO and founder Ryan Kunkel to serve as its vice-chairman and an independent director. Kunkel is a seasoned cannabis expert and entrepreneur with experience in operations, fundraising, and application development. "As our operations continue to expand and we open our first dispensaries in Los Angeles and acquire Kush Bar dispensaries from High Tide in Alberta, Canada, it's imperative for Halo to look at the big picture and bring Ryan to our senior team," Louisa Mojela, ...
Psychedelics Could be Your Next Multi-Billion-Dollar Opportunity It may only be a matter of time before mind-altering drugs make their way into Big Pharma treatments for mental health issues, such as depression, anxiety, obsessive compulsive disorder, trauma, and addiction. If that happens, the industry could be worth well over $100 billion, as noted by analyst at Eight Capital, benefiting companies such as Silo Wellness (CSE:SINO), Compass Pathways Inc. (NASDAQ:CMPS), HAVN Life Sciences Inc. (CSE:HAVN), and Tryp Therapeutics Inc. (CSE:TRYP). Helping even more, a bill to decrim...